Vivione Biosciences Inc. announced the termination of Ted Moskal as President of Vivione and its operating subsidiary, Vivione Biosciences, LLC. Day-to-day responsibilities with the FDA will be assumed by Chief Medical Officer, Dr. Matthew Gombrich.